dr. natale on the evolution of immunotherapy in nsclc
Published 4 years ago • 520 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
2:03
dr. natale on the utility of pd-l1 and tmb in lung cancer
-
1:32
dr. gettinger on the evolution of immunotherapies in lung cancer
-
4:43
the evolution of immunotherapy in cancer
-
1:21
dr. nadler on the impact of immunotherapy in squamous nsclc
-
27:55
ronald natale immunotherapies for lung cancer and lung toxicities
-
1:22
dr. bauml on the use of immunotherapy in oligometastatic nsclc
-
26:13
immunotherapies in lung cancer | 2022 evolution conference
-
1:55
dr. gandara on the impact of immunotherapy on the tumor microenvironment in lung cancer
-
0:36
dr. camidge on the fda approval of pembrolizumab for squamous nsclc
-
0:39
dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc
-
1:08
dr. donington on the role of neoadjuvant immunotherapy in stage ii nsclc
-
1:39
dr. antonia on the promise of immunotherapy in nsclc
-
1:33
dr. chaft on the rise of immunotherapy in lung cancer
-
1:54
the evolving landscape of immunotherapy in nsclc
-
1:35
dr. lee on the combination of immunotherapy and tkis in mrcc
-
1:59
dr. herbst on key immunotherapy findings in nsclc
-
1:45
dr. langer on the future on immunotherapy for treatment of nsclc
-
2:34
the future of immunotherapy in nsclc
-
0:53
dr. schwartz on the results of the pacific trial